Fundraising Fox
Cardiosense
Chicago, US · Founded 2020 · Delaware corporation · 38 employees on LinkedIn · 9 known investors
Find your way into Cardiosense
Sign up to see every warm intro you have to Cardiosense
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardiosense team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
Founders & leadership
Cardiosense was founded in 2020 by Amit Gupta, Mozziyar Etemadi, Omer Inan, and Andrew Carek.
AG
Amit GuptaCo-founder, AdvisorHe co-founded the company in 2020 and served as its CEO before moving into the Chief Strategy Officer role in 2025. He previously spent nearly a decade at Ishi Systems, advancing from product manager to Director of Product, Analytics, and earlier held roles at BioXcel Corporation and ABB Robotics.
ME
Mozziyar EtemadiCo-founder, Head of AI
OI
Omer InanChief Scientific Officer, Co-Founder, and Board MemberHe is the Linda J. and Mark C. Smith Chaired Professor of Electrical and Computer Engineering at Georgia Tech, where he also serves as Associate Chair for Entrepreneurship and Strategic Initiatives and as a Regents Entrepreneur, having joined the faculty in 2013. In addition to co-founding Cardiosense and serving on its board, he is Chief Scientific Officer at Biozen.
AC
Andrew CarekCo-Founder, CTOBefore co-founding the company in 2020, he was a postdoctoral researcher at Northwestern University's Feinberg School of Medicine and completed a research internship at Microsoft.
EM
Eric MeizlishChief Executive OfficerHe previously served as CEO of BioProcure and Prendio, and spent nearly a decade at GHX, where he co-founded Lumere and served as its President and Chief Strategy Officer before moving into strategy and corporate development leadership roles. Earlier in his career he was a long/short equity investor at Citadel and interned at the Yale University Investments Office.
JD
John D. MartinChief Medical OfficerJohn D. Martin is a physician with experience as a U.S. Air Force surgeon, founder of a software company, inventor of medical devices, Chief of Heart and Vascular Services at a regional health system, President of a cardiology practice, VP of Physician Operations for a health system, and Chief Medical Officer of a digital health company that grew to public status. He now serves as Chief Medical Officer at Cardiosense.
AA
Arezou AzarChief Regulatory & Compliance OfficerArezou Azar is Chief Regulatory & Compliance Officer at Cardiosense and previously held regulatory and product roles at Apple, Verily/Google, Eko Devices, AliveCor, and Cardiologs, as well as a fellowship in FDA's Center for Devices and Radiological Health. She holds a PhD in Biomedical Engineering with focus on machine learning in health applications.
Board
JT
Jeff TerrellBoard Member2022–2025Director at Cardiosense, which develops wearable sensing hardware and deep-learning algorithms that turn physiological signals into clinical insights for cardiovascular disease detection and management.
DG
Daniel GottliebBoard of DirectorsDaniel Gottlieb is a director at Cardiosense, which develops wearable sensing hardware and deep-learning algorithms that turn physiological signals into clinical insights for cardiovascular disease detection and management. He has medtech and biotech operating experience spanning marketing, corporate strategy, business development, and corporate venture across VC-backed startups, a late-stage public company, and large strategics.
JT
Jeffrey TrostBoard director
LP
BS
Bimal ShahBoard director
Investors · 9
BayMed Venture Partnerslisted by BayMed Venture PartnersSan Francisco
How we know: BayMed Venture Partners's portfolio page · Not right? Tell us
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · a partner's Signal profile · hatterasvp.com · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Cross-Border Impact Ventureslisted by Cross-Border Impact VenturesToronto · $2M – $10M
How we know: Cross-Border Impact Ventures's portfolio page · Not right? Tell us
Laerdal Million Lives Fundlisted by Laerdal Million Lives FundSan Francisco · $1M – $5M
How we know: hatterasvp.com · Not right? Tell us
Portal Innovationslisted by Portal InnovationsChicago
How we know: Portal Innovations's portfolio page · hatterasvp.com · Not right? Tell us
Arboretum VenturesreportedAnn Arbor · $5M – $15M
How we know: a partner's Signal profile · Not right? Tell us
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
How we know: board seat on SEC Form D · hatterasvp.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 1
UnityPoint Health Ventures
Funding
SEC filings, press & company announcements$35.2M disclosed across 2 of 3 rounds · 2022–2026
- Undisclosed amountSeries AJan 2026
Broadview Ventures (lead), Hatteras Venture Partners (lead), Laerdal Million Lives Fund, OSF Ventures, Portal Innovations, UnityPoint Health Ventures
Source ↗
▶$26.1MraisedAug 2026 · 30 investors · Other Health CareRule 506(b)
▶$26.1MraisedAug 2026 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric MeizlishExecutive Officer, Director
- Andrew Michael CarekExecutive Officer
- Daniel GottliebDirector
- Bimal ShahDirector
- Jeffrey TrostDirector
- Lauren Pierce FlickingerDirector
- Omer Tolga InanExecutive Officer, Director
- Offering amount
- $42M
- Amount sold
- $26.1M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.1MraisedDec 2022 · 28 investors · OtherRule 506(b)
▶$9.1MraisedDec 2022 · 28 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jeff TerrellDirector
- Omer Tolga InanDirector
- Amit K. GuptaExecutive Officer, Director
- Andrew Michael CarekExecutive Officer
- Daniel GottliebDirector
- Offering amount
- $17.7M
- Amount sold
- $9.1M
- Minimum investment
- $20K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
AliveCorAliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.
DigitalDigital.Health is a clinician-curated discovery platform where clinicians, health systems, and consumers find, compare, and select digital health solutions. It offers structured company and product listings that feed its comparison engine, recommendation system, and AI-enabled search for buyers in active evaluation.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Cardiac Insight Inc.Cardiac Insight develops ECG-based cardiac diagnostic products, including software using international consensus criteria, to help clinicians detect and screen for cardiac conditions such as sudden cardiac death risk in athletes. The company serves physicians and clinical settings in the cardiology and sports cardiology space, and is a subsidiary of Dreamtech.
Companies working in the same space as Cardiosense.
In the news
Frequently asked questions
- What does Cardiosense do?
- Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
- Who founded Cardiosense?
- Cardiosense was founded by Amit Gupta, Mozziyar Etemadi, Omer Inan, Andrew Carek in 2020.
- Who are Cardiosense's investors?
- Cardiosense's investors include BayMed Venture Partners, Broadview Ventures, Cross-Border Impact Ventures, Laerdal Million Lives Fund, OSF Ventures, Portal Innovations, Arboretum Ventures, Hatteras Venture Partners.
- How much funding has Cardiosense raised?
- Cardiosense has disclosed $35.2M raised across 2 of its 3 known rounds.
- Where is Cardiosense headquartered?
- Cardiosense is headquartered in Chicago, US.